[1] Schleimer R P. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis[J]. Annu Rev Pathol, 2017, 12: 331-357.
[2] Wang X D, Sima Y T, Zhao Y, et al. Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors[J]. J Allergy Clin Immunol, 2023, 151(2): 458-468.
[3] Hughes C E, Nibbs R J B. A guide to chemokines and their receptors[J]. FEBS J, 2018, 285(16): 2944-2971.
[4] 李颖, 王向东, 王鸿, 等. CC类趋化因子在慢性鼻窦炎的表达[J]. 首都医科大学学报, 2013, 34(6): 795-798.
[5] De Corso E, Baroni S, Battista M, et al. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation[J]. Int Forum Allergy Rhinol, 2014, 4(8): 617-624.
[6] Wang C, Lou H, Wang X, et al. Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2015, 135(4): 922-929.
[7] Fokkens W J, Lund V J, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl 29): 1-464.
[8] Wang M, Zhang N, Zheng M, et al. Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2019, 144(5): 1254-1264.
[9] Zeng M, Li Z Y, Ma J, et al. Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study[J]. BMC Immunol, 2015, 16: 37.
[10] Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity[J]. Annu Rev Pathol, 2020, 15: 123-147.
[11] Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233(9): 6425-6440.
[12] Banks C A, Schlosser R J, Wang E W, et al. Macrophage infiltrate is elevated in CRSwNP sinonasal tissue regardless of atopic status[J]. Otolaryngol Head Neck Surg, 2014, 151(2): 215-220.
[13] Krysko O, Holtappels G, Zhang N, et al. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis[J]. Allergy, 2011, 66(3): 396-403.
[14] Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5): 1344-1353.
[15] Gevaert P, Han J K, Smith S G, et al. The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2022, 12(11): 1413-1423.
[16] Delemarre T, Holtappels G, De Ruyck N, et al. A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2021, 147(1): 179-188.e2.
[17] Wen W P, Liu W L, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy[J]. J Allergy Clin Immunol, 2012, 129(6): 1522-1528.e5.
[18] Wang L, Yang M, Wang X, et al. Glucocorticoids promote CCL20 expression in keratinocytes[J]. Br J Dermatol, 2021, 185(6): 1200-1208.
[19] Zijlstra G J, Fattahi F, Rozeveld D, et al. Glucocorticoids induce the production of the chemoattractant CCL20 in airway epithelium[J]. Eur Respir J, 2014, 44(2): 361-370.
|